Clinical Trials

Showing trials with last updates posted in 2022.

NCT02657889 | COMPLETED | PHASE1/PHASE2
122 participants

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2022-12-01
Start Date:
2016-04-15
Completion:
2018-05-14
Conditions
  • Neoplasms
  • Triple Negative Breast Cancer
  • Ovarian Cancer
  • Breast Cancer
  • Metastatic Breast Cancer
  • Advanced Breast Cancer
  • Stage IV Breast Cancer
  • Fallopian Tube Cancer
  • Peritoneal Cancer
Interventions
  • DRUG
  • BIOLOGICAL
NCT01165645 | WITHDRAWN | NA
0 participants

Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2022-12-01
Start Date:
2010-11-30
Completion:
2011-05-31
Conditions
  • Hodgkin Lymphoma
  • Stage I Adult Hodgkin Lymphoma
  • Stage II Adult Hodgkin Lymphoma
  • Stage III Adult Hodgkin Lymphoma
  • Stage IV Adult Hodgkin Lymphoma
Interventions
  • DRUG
  • GENETIC
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page